With FDA clearance in hand, Rivanna highlighted that it will accelerate the development of further AI capabilities for the Accuro XV system.

A roundup of recent products in the GNSS and inertial positioning industry from the March-April 2026 issue of GPS ...

Silvaco Stock: Consider Early Investment in New Semiconductor Silvaco Group (NASDAQ:SVCO) reported first-quarter fiscal 2026 ...

VisionWave expands its IP portfolio with xCalibre filing, strengthening its position in AI driven defense and computer vision ...

New Wi-Fi 7 access points designed to provide reliable, high-speed connectivity and key deployment made at University of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Patching is not enough: applications embedding the insecure library will need to be rebuilt, and affected tokens and cookies expired. Developers are advised to check their applications after Microsoft ...

The wrong computer monitor can cause everything from physical discomfort to productivity slowdowns. Costco buyers swear by ...

Chemists and computer scientists tapped AI to find new disinfectants to combat the growing threat of dangerous "superbugs." ...

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro® XV Diagnostic ...

Penetration tests of AI systems expose significantly higher severe-flaw density when compared to legacy apps. New attack ...